ATM pathogenic variants, such as homozygous or compound heterozygous changes, cause ataxia telangiectasia, a syndromic disease characterized by progressive cerebellar ataxia, oculomotor apraxia, immunodeficiency, and enhanced cancer predisposition [61]. This evidence concerns the gene ATM and ataxia telangiectasia.